James E. Galvin, MD, MPH
Articles
Clinical Application and Potential of Cognitive Amyloid Risk Measure: James Galvin, MD, MPH
June 4th 2025The professor of neurology at the Miami Miller School of Medicine detailed the clinical potential of Cognivue’s Amyloid Risk Measure (CARM) for identifying individuals with cognitive impairment likely related to amyloid pathology. [WATCH TIME: 5 minutes]
Expanding the Pathways to Treat Dementia With Lewy Bodies: James Galvin, MD, MPH
December 7th 2022The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine detailed the need for improved biomarkers of dementia with Lewy bodies and whether research in Alzheimer disease helps propel the field. [WATCH TIME: 3 minutes]
Addressing Unmet Needs of Dementia With Lewy Bodies: James Galvin, MD, MPH
December 2nd 2022The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine discussed the treatment differences and unmet needs between dementia with Lewy bodies and Alzheimer disease. [WATCH TIME: 4 minutes]
COVID-19’s Potential Effect on Dementia Risk: James E. Galvin, MD, MPH
September 1st 2021The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine discussed the current understanding of COVID-19 and its associations with cognitive decline and Alzheimer disease.
Dementia Research in Multicultural Communities: James E. Galvin, MD, MPH
August 30th 2021The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine discussed projects dedicated towards improving dementia recognition and care within multicultural communities.
Associations Between Greenspace and Cognitive Performance: James E. Galvin, MD, MPH
August 16th 2021The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine discussed the clinical significance of his findings on neighborhood tree canopy and brain health.
